We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

ACROBiosystems  Logo


ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine. Our way of addressing challenges in biologics development is to offer a comprehensive array of tools and solutions designed for each development phase. Starting from discovery and development and moving beyond commercialization, we strive to deliver high-quality solutions that support each step of the development process. This means bringing together innovation and technology through product development and collaborations to help our customers achieve translatable results in the clinic and beyond.

Latest ACROBiosystems Content

Cell and Gene Therapy Symposium, March 20-21: Experts discuss cancer immunotherapy, gene vectors, stem cells, and precision oncology
Online Event

Cell and Gene Therapy 2024

Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.

Organoids in Industry: Disease Modeling Platforms To Accelerate Drug Discovery

In this Teach me in 10 we're exploring disease modeling platforms that expedite drug discovery processes.
Comprehensive coverage of GMP products in your cell therapy production process

Comprehensive Coverage of GMP Products in Your Cell Therapy Production Process

Integrating our GMP proteins into your manufacturing process has never been easier. With our affordable GMP growth factors, maintain that flexibility to either directly use GMP grade or slowly transition with our 'pre-GMP' premium grade proteins.
Elevating Your Cell and Gene Therapy with High-quality Solutions

Elevating Your Cell and Gene Therapy With High-Quality Solutions

Manufacturing cell therapies and other innovative medicines can be a challenge. Our tools and solutions are designed to work with you from the first step. Want to learn more? Explore our webpage and brochure and find what’s right for you!
Neurodegenerative Disease

Model Neurodegenerative Disease Traits More Closely

This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.
Cell and Gene Therapy 2023

Products & Services Across Cell Therapy Research & Development

Speaking at Cell & Gene Therapy 2023,Tracy Zhao from ACROBiosystems, presented their talk on products and services across cell therapy research and development.
Drug Targets

Accelerating the Discovery of Transmembrane Protein-Targeting Drugs

Drug discovery is a time-consuming, resource-intensive part of developing therapeutic targets. This is especially true for commonly considered 'undruggable' targets such as transmembrane proteins.
Diving Deep Into Cell Therapy: An Industry Perspective content piece image

Diving Deep Into Cell Therapy: An Industry Perspective

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Targeting the TME and the Development of Effective Therapeutics Against Solid Tumors content piece image

Targeting the TME and the Development of Effective Therapeutics Against Solid Tumors

Speaking at The Landscape of Cancer Research 2021, Prajwal Paudel from ACROBiosystems delivered their talk on the development of effective therapeutics against solid tumors.
ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy content piece image

ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy

Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.